AnaCardio AB announced that it has received SEK 150 million in a round of funding led by Flerie Invest AB, and Industrifonden on September 7, 2022. The transaction also included participation from 3B Health Ventures, returning investors Karolinska Development AB , and individual investors Fredrik and Ann-Helene Ljungström.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.562 SEK | -2.38% | -4.87% | -8.01% |
Apr. 26 | Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.01% | 40.37M | |
-6.46% | 180B | |
+3.39% | 112B | |
-3.68% | 68.53B | |
+5.44% | 51.97B | |
+5.70% | 44.08B | |
+5.62% | 42.23B | |
+25.42% | 32.43B | |
+16.72% | 26.39B | |
-4.29% | 24.97B |
- Stock Market
- Equities
- KDEV Stock
- News Karolinska Development AB
- AnaCardio AB announced that it has received SEK 150 million in funding from Industrifonden, Karolinska Development AB, Flerie Invest AB, and other investors